Chordoma treatment in Istanbul — get 3 personalized clinic matches

Author of 40+ peer-reviewed publications in tumor biology/immunology and systemic therapy (immunotherapy and targeted therapy); member of the Turkish Medical Oncology Association and the European Head & Neck Society.

Why patients choose Dr. Bülent Karagöz:

• Treatment based on U.S. protocols through Anadolu Medical Center’s strategic collaboration with a leading U.S. institution — Johns Hopkins Medicine.
• 40+ scientific publications in tumor biology/immunology and systemic therapy (immunotherapy and targeted therapy).
• Former department head (GATA) and professor/department chair (Okan University, Turkey) — leadership and clinical experience at major centers.
• Treats solid tumors (e.g., breast, lung, colorectal), applying modern regimens guided by tumor biology.
• Anadolu Medical Center holds ESMO designation and JCI accreditation — meaning the doctor treats according to international protocols, within a multidisciplinary team, with strict safety oversight.

Dr. Eda Tanrikulu, an Anadolu Medical Center oncologist, places in the top three in Turkey on the national medical oncology exam. She has served as a head researcher for multiple international cancer studies.

• Specializes in medical oncology and systemic chemotherapy treatments
• Former head of the medical oncology unit at Haydarpaşa Numune Training and Research Hospital
• Over _doctor_689_years_ of medical training and practice since graduation
• Certified as a specialist in both internal medicine and medical oncology

Dr. Solak specializes in treating rare cancers like Chordoma, with training at Hacettepe University Cancer Institute and MD Anderson Cancer Center.

• Completed fellowship at Hacettepe University Cancer Institute
• Worked at The University of Texas MD Anderson Cancer Center
• Experienced in treating various complex cancers
• Specializes in breast, testicular, and gastrointestinal cancers

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.